InsiderTrades

Form 4 for TECH Bio-Techne

Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-01 · accession 0001062993-25-001660 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-04 2025-02-01 TECH McManus Matthew Pres - DGS F - Tax $73.55 -1,642 2,978 -36% -$120.8K
D 2025-02-04 2025-02-01 TECH McManus Matthew Pres - DGS M - OptEx $0.00 +4,620 4,620 New $0
D 2025-02-04 2025-02-01 TECH McManus Matthew Pres - DGS M - OptEx $0.00 -4,620 9,241 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-01 F D 1,642 $73.55 2,978 D — —
2 Common Common Stock 2025-02-01 M A 4,620 $0.00 4,620 D — —
3 Derivative Restricted Stock Units 2025-02-01 M D 4,620 $0.00 9,241 D — · — to — 4,620 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.